Media Registration Open for ENDO 2022

Members of the media can now register to cover the latest advances in hormone health and science at ENDO 2022, the Endocrine Society’s annual meeting being held on June 11-14 in Atlanta, Ga., as well as virtually in our state-of-the-art digital platform.

The Society’s first-ever hybrid annual meeting will give colleagues the option to experience top-flight educational programming in person as well as reconnect with endocrine colleagues.

ENDO 2022 offers journalists the opportunity to discuss groundbreaking research with world-renowned experts in diverse fields, including obesity, diabetes, reproductive health, endocrine-disrupting chemicals, menopause, bone health and thyroid cancer. The meeting is considered the gold standard of leading global conferences in endocrinology research and clinical care. The hybrid event is expected to draw thousands of people from all over the world.

This year’s program will have more than 100 in-person and virtual sessions, 50+ in-person only sessions, 30 oral sessions and six plenaries. The Society will host several virtual press conferences and distribute news releases on scientific findings being released at the premier event on hormone research, health science and endocrinology.

News Media Registration Information

To register as media for ENDO 2022, please complete the online registration form. Eligible members of the news media will receive a complimentary access to all meeting sessions and news conferences.

Media registrations are approved at the discretion of the Endocrine Society. Eligibility requirements are listed in our online newsroom. Media approved for attendance will receive official notification via email from Endocrine Society staff.

More information is available at https://www.endocrine.org/endo2022.

You may also like

  • Endocrine Society Endorses Bipartisan Bill to Address Insulin Affordability 

    INSULIN Act would expand insulin co-pay cap to commercial market and encourage competition. The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA).   This historic legislation would cap out-of-pocket insulin costs at $35 per month for people on private insurance, protecting access to this life-saving medication for millions of people with diabetes. The legislation also would create a program to…

  • In Memoriam: Martin Savage 1941-2026

    Martin O. Savage, Emeritus Professor of Pediatric Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, passed away on February 24, 2026. Martin Savage was a kind, generous, quietly spoken man, an inspirational pediatrician and an internationally renowned clinician scientist. He was passionate about teaching…

Find more in